tiprankstipranks
Rapport Therapeutics, Inc. (RAPP)
NASDAQ:RAPP
US Market
Holding RAPP?
Track your performance easily

Rapport Therapeutics, Inc. (RAPP) Technical Analysis

20 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
3Bearish
Rapport Therapeutics, Inc.’s (RAPP) Moving Averages Convergence Divergence (MACD) indicator is -0.39, suggesting Rapport Therapeutics, Inc. is a Buy.
Rapport Therapeutics, Inc.’s (RAPP) 20-Day exponential moving average is 23.38, while Rapport Therapeutics, Inc.’s (RAPP) share price is $23.09, making it a Sell.
Rapport Therapeutics, Inc.’s (RAPP) 50-Day exponential moving average is 23.15, while Rapport Therapeutics, Inc.’s (RAPP) share price is $23.09, making it a Sell.

Rapport Therapeutics, Inc. (RAPP) Pivot Points

Nov 27, 2024, 04:14 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
20.23
21.06
21.79
22.62
23.35
24.17
24.90
Fibonacci
21.06
21.65
22.02
22.62
23.21
23.58
24.17
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Rapport Therapeutics, Inc. (RAPP) Moving Averages

Nov 27, 2024, 04:14 AM
Period
Simple
Exponential
MA5
22.28Buy
22.58Buy
MA10
22.73Buy
22.89Buy
MA20
24.02Sell
23.38Sell
MA50
22.88Buy
23.15Sell
MA100
22.21Buy
22.59Buy
Rapport Therapeutics, Inc.’s (RAPP) 10-Day exponential moving average is 22.89, while Rapport Therapeutics, Inc.’s (RAPP) share price is $23.09, making it a Buy.
Rapport Therapeutics, Inc.’s (RAPP) 100-Day exponential moving average is 22.59, while Rapport Therapeutics, Inc.’s (RAPP) share price is $23.09, making it a Buy.
Rapport Therapeutics, Inc.’s (RAPP) stock price is $23.09 and Rapport Therapeutics, Inc.’s (RAPP) 50-day simple moving average is 22.88, creating a Buy signal.
Rapport Therapeutics, Inc.’s (RAPP) stock price is $23.09 and Rapport Therapeutics, Inc.’s (RAPP) 100-day simple moving average is 22.21, creating a Buy signal.

Rapport Therapeutics, Inc. (RAPP) Technical Indicators

Nov 27, 2024, 04:14 AM
Name
Value
Implied Action
RSI (14)
48.65
Neutral
STOCH (9,6)
33.37
Neutral
STOCHRSI (14)
30.75
Neutral
MACD (12,26)
-0.39
Buy
ADX (14)
17.17
Buy
Williams %R
-62.97
Buy
CCI (14)
-43.25
Neutral
ATR (14)
1.86
-
Ultimate Oscillator
49.44
Neutral
ROC
-2.24
Sell
Rapport Therapeutics, Inc.’s (RAPP) Relative Strength Index (RSI) is 48.65, creating a Neutral signal.
Rapport Therapeutics, Inc.’s (RAPP) Trend Strength Indicator (ADX) is 17.17, creating a Buy signal.
Rapport Therapeutics, Inc.’s (RAPP) Commodity Channel Index (CCI) is -43.25, creating a Neutral signal.
Rapport Therapeutics, Inc.’s (RAPP) Price Rate of Change (ROC) is -2.24, creating a Sell signal.

FAQ

Is RAPP a Buy, Hold, or Sell?
Based on RAPP’s technical indicators, RAPP is a Buy.
    What is RAPP’s RSI (14)?
    RAPP’s RSI (14) is 48.65, which suggests RAPP is a Neutral.
      What is RAPP’s MACD?
      RAPP’s MACD is -0.39, which suggests RAPP is a Buy.
        What is RAPP’s 5-day moving average?
        RAPP’s 5-day moving average is 22.28, which suggests RAPP is a Buy.
          What is RAPP’s 20-day moving average?
          RAPP 20-day moving average is 24.02, which suggests RAPP is a Sell.
            What is RAPP’s 50-day moving average?
            RAPP’s 50-day moving average is 22.88, which suggests RAPP is a Buy.
              What is RAPP’s 200-day moving average?
              Currently, no data Available
              What is RAPP’s Williams % R (14)?
              RAPP’s Williams % R (14) is -62.97, which suggests RAPP is a Buy.
                What is RAPP’s CCI (14)?
                RAPP’s CCI (14) is -43.25, which suggests RAPP is a Neutral.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis